Local Institution - 1612

Washington D.C., District of Columbia 20010

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma — Completed